BIANCHINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 6.989
EU - Europa 6.948
AS - Asia 1.233
AF - Africa 33
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 15.212
Nazione #
US - Stati Uniti d'America 6.841
PL - Polonia 3.168
RU - Federazione Russa 1.591
IT - Italia 705
IE - Irlanda 470
SE - Svezia 420
SG - Singapore 298
HK - Hong Kong 277
CN - Cina 274
GB - Regno Unito 160
DE - Germania 156
CA - Canada 146
IN - India 126
JO - Giordania 104
FI - Finlandia 84
VN - Vietnam 81
CH - Svizzera 64
KR - Corea 43
UA - Ucraina 31
CI - Costa d'Avorio 29
ES - Italia 22
TR - Turchia 17
AT - Austria 16
BE - Belgio 16
NL - Olanda 15
FR - Francia 14
BR - Brasile 4
CZ - Repubblica Ceca 4
DK - Danimarca 3
JP - Giappone 3
SK - Slovacchia (Repubblica Slovacca) 3
CL - Cile 2
EU - Europa 2
HR - Croazia 2
PK - Pakistan 2
SC - Seychelles 2
TW - Taiwan 2
AU - Australia 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ID - Indonesia 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
NG - Nigeria 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
TN - Tunisia 1
Totale 15.212
Città #
Warsaw 3.168
Santa Clara 1.078
Fairfield 929
Chandler 510
Ashburn 492
Dublin 466
Woodbridge 411
Seattle 375
Houston 347
Cambridge 333
Wilmington 288
Singapore 241
Florence 230
Hong Kong 172
Lawrence 170
Altamura 165
Ann Arbor 163
Mcallen 145
Montréal 134
Princeton 133
Beijing 86
Munich 85
Boston 78
Mumbai 72
Dong Ket 70
Moscow 69
Shanghai 66
Jacksonville 64
San Diego 63
Buffalo 60
Bern 58
Boardman 53
Medford 48
Pune 44
Kent 38
Abidjan 29
Phoenix 25
Falls Church 24
Norwalk 24
Seongnam 21
Los Angeles 18
New York 18
Barcelona 17
Milan 16
Seoul 16
Vienna 16
Izmir 15
Yubileyny 14
Brussels 12
Hillsboro 12
Rome 12
Andover 11
Helsinki 11
London 11
Zhengzhou 10
Toronto 9
Prato 8
Redmond 8
Bremen 7
Padova 7
Redwood City 7
Arezzo 6
Bari 6
Gavirate 6
Guangzhou 6
Scandicci 6
Shenzhen 6
Council Bluffs 5
Chions 4
Frankfurt am Main 4
Nanjing 4
Olomouc 4
Prescot 4
Amsterdam 3
Bratislava 3
Brescia 3
Camerino 3
Castelliri 3
Catania 3
Central 3
Chiavenna 3
Chiesina Uzzanese 3
Copenhagen 3
Ghent 3
Guwahati 3
Hangzhou 3
Hanoi 3
Lappeenranta 3
Laurel 3
Nave 3
Ottawa 3
Palermo 3
Santa Barbara 3
Tappahannock 3
Viterbo 3
Auburn Hills 2
Avezzano 2
Barletta 2
Belo Horizonte 2
Bologna 2
Totale 11.419
Nome #
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. 755
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 287
Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells 284
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 282
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 280
Identification of novel human breast carcinoma (MDA-MB-231) Cell growth modulators from a carbohydrate-based diversity oriented synthesis library 275
The acidic microenvironment as a possible niche of dormant tumor cells 266
¹²⁵I-radiolabeled morpholine-containing arginine-glycine-aspartate (RGD) ligand of αvβ₃ integrin as a molecular imaging probe for angiogenesis. 264
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits 262
Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells 262
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 256
Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma. 252
Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. 248
IFNgamma and TNFalpha account for a pro-clonogenic activity secreted by activated murine peritoneal macrophages. 245
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 214
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 213
Synthesis and conformational analysis of peptides embodying 2,3-methanopipecolic acids 209
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 196
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 196
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 194
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 188
Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions 186
"β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells, 184
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 172
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy 172
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 169
Anoikis resistance as a further trait of acidic-adapted melanoma cells 159
Cancer glycolytic dependence as an new target of olive leaf extract 158
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 157
Stereodivergent synthesis of 5-aminopipecolic acids and application in the preparation of a cyclic RGD peptidomimetic as a nanomolar αvβ3 integrin ligand 155
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer 155
Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools. 152
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 141
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 140
β3-adrenoceptor as a potential immuno-suppressor agent in melanoma 137
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis 135
Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression 130
Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach 128
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 127
Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin. 126
Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells. 126
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. 124
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells 124
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style 122
Identification of highly potent and selective MMP2 inhibitors addressing the S1′ subsite with D-proline-based compounds 121
Cyclopropane Pipecolic Acids as Templates for Linear and Cyclic Peptidomimetics: Application in the Synthesis of an Arg-Gly-Asp (RGD)-Containing Peptide as an αvβ3 Integrin Ligand 120
FDG uptake in cancer: a continuing debate 119
CD63 Tetraspanin Is a Negative Driver of Epithelial-to-Mesenchymal Transition in Human Melanoma Cells 118
β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment 118
Click-chemistry-derived triazole ligands of arginine−glycine−aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis 115
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 113
Cyclic RGD peptidomimetics containing 4- and 5-aminocyclopropane pipecolic acid (CPA) templates as dual aVb3 and a5b1 integrin ligands 113
Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. 112
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells 112
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis 111
Oleuropein-rich leaf extract as a broad inhibitor of tumour and macrophage iNOS in an apc mutant rat model 111
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells 110
Angiopoietin like 7, a novel pro-angiogenetic factor over-expressed in cancer 109
22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis. 109
Endothelial sphingosine kinase/SPNS2 axis has a critical role in migration and vessel-like formation of human mesoangioblasts 109
Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis 108
A study of a d-proline peptidomimetic inhibitor of melanoma and endothelial cell invasion through activity towards MMP-2 and MMP-9 108
Combination of click chemistry and sulfonamides to develop three-armed triazole compounds 105
Inhibition of lipoxygenase pathway in macrophages co-cultivated with tumor cells 104
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 104
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 104
EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells 102
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 101
Acidic pH via NF-κB favours VEGF-C expression in human melanoma cells 100
Marie Ménard apples with high polyphenol content and a low-fat diet reduce 1,2-dimethylhydrazine-induced colon carcinogenesis in rats: Effects on inflammation and apoptosis. 99
Metabolic reprogramming as a continuous changing behavior of tumor cells 98
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 98
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation 97
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression 97
Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis 96
Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. 94
Synthesis and preclinical evaluation of a novel, selective 111In-labelled aminoproline-RGD-peptide for non-invasive melanoma tumor imaging 94
The change in leukotrienes and lipoxins in activated mouse peritoneal macrophages 93
Expression of a metastatic phenotype in IFNs-primed/TNFalpha-activated B16 murine melanoma cells: role of JAK1/PKCdelta signal transduction factors. 92
Lipoxygenase products of murine peritoneal macrophages at different levels of activation 91
Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma 90
Design, synthesis and evaluation of RGD peptidomimetic – Gold nanostar conjugates as M21 cell adhesion inhibitors 90
Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. 88
Stereochemical Assignment, Anti-Inflammatory Properties, and Receptor for the Omega-3 Lipid Mediator Resolvin E1 87
Oleuropein-enriched olive leaf extract affects BRAF melanoma cells metabolism 83
Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis 82
Hypoxia-mediated overexpression of cytokine receptors: a mechanism of tumor progression in B16 melanoma cells 82
FGF2 in Human Melanoma Progression: The Antithetical Functions of Different Isoforms 81
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 79
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer 78
Changes of the secretion of NO and TNFalpha by peritoneal murine inflammatory macrophages co-cultivated with B16 melanoma cells 75
Modular synthesis of 2,4-diaminoanilines as CNS drug-like non-covalent inhibitors of asparagine endopeptidase 73
Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice 71
Gold nanoparticles functionalized with RGD-semipeptides: a simple yet highly effective targeting system for αVβ3 integrins 71
Tumor cells and tumor-associated macrophages contribute to the generation of the uPA system and MMP-9 70
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 70
TNFα receptor1 drives hypoxia-promoted invasiveness of human melanoma cells 67
Oleuropein affects braf melanoma cells and potentiates chemotherapy cytotoxicity 67
Enantioselective Synthesis of cis and trans 4-Aminopipecolic Acids as γ-Amino Acids for the Construction of Cyclic RGD-Containing Peptidomimetics Antagonists of αVβ3 Integrin 67
Oleuropein potentiates the cytotoxic activity of dacarbazine against melanoma cells. 66
Totale 14.349
Categoria #
all - tutte 40.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.036 0 0 0 0 374 284 266 349 280 184 253 46
2020/20212.097 163 208 67 307 145 187 145 158 198 313 93 113
2021/2022898 57 82 64 43 28 42 47 62 36 67 126 244
2022/20232.361 196 497 140 141 145 393 289 142 237 16 72 93
2023/20241.024 33 99 129 42 58 150 52 259 30 46 80 46
2024/20253.515 193 611 352 964 1.395 0 0 0 0 0 0 0
Totale 15.461